No clinically important response to treatment ‐ short term · patients with schizophrenia
SULPIRIDE AUGMENTATION OF ANY ANTIPSYCHOTIC DRUG may leads to lower SENSITIVITY ‐ Global/mental state: No clinically important response… compared with ANY ANTIPSYCHOTIC DRUG (low certainty).
1 finding from 1 review
Relapse · patients with schizophrenia
CLOZAPINE probably leads to lower relapse ‐ short term compared with TYPICAL ANTIPSYCHOTICS ‐ OVERALL (moderate certainty).
2 findings from 1 review
Global state: no improvement ‐ medium termAs defined in each study · patients with schizophrenia
CLOZAPINE probably leads to lower global impression: 1. Not clinically improved ‐ short term compared with TYPICAL ANTIPSYCHOTICS (moderate certainty).
2 findings from 1 review
Intervention not reported
Mental state: 1a. Overall no clinically important improvement (BPRS) ‐ short term 25‐30% change BPRS1,2 ( · people with schizophrenia
The intervention showed no clear difference in mental state: 1a. Overall no clinically important improvement (BPRS)… (low certainty).
1 finding from 1 review
Intervention not reported
quality of life scale ‐ mean improvement in total score of Short Form 36 · patients with hypersomnia (excessive daytime sleepiness) in myotonic dystrophy
1 finding from 1 review
Leaving the study early · patients with schizophrenia
Beta‐blockers showed no clear difference in global state: 1. Leaving the study early ‐ Short term compared with placebo (low certainty).
1 finding from 1 review
Relapse · patients with schizophrenia
Beta‐blockers showed no clear difference in global state: 2. Relapse ‐ short term compared with placebo (low certainty).
1 finding from 1 review
Adverse effects: 1. Death ‐ short term · patients with schizophrenia
1 finding from 1 review
Adverse effect: 2. General ‐ Short term · patients with schizophrenia
Beta‐blockers showed no clear difference in adverse effect: 2. General ‐ Short term compared with placebo (low certainty).
1 finding from 1 review
Adverse effects: 3. Specific ‐ cardiovascular ‐ short term · patients with schizophrenia
Beta‐blockers showed no clear difference in adverse effects: 3. Specific ‐ cardiovascular ‐ short term compared with placebo (low certainty).
1 finding from 1 review
Weight gain · promoting short‐term growth of preterm infants
2 findings from 1 review
Length gain, cm/week (high MCT vs low MCT) · promoting short‐term growth of preterm infants
1 finding from 1 review
Growth: head circumference (cm/week) · promoting short‐term growth of preterm infants
1 finding from 1 review
Skinfold thickness gain (mm/week) (high MCT vs low MCT) · promoting short‐term growth of preterm infants
1 finding from 1 review
Gastrointestinal intolerance · promoting short‐term growth of preterm infants
1 finding from 1 review
NEC · promoting short‐term growth of preterm infants
1 finding from 1 review
Neurodevelopmental outcomes · promoting short‐term growth of preterm infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Long‐term growth outcomes · promoting short‐term growth of preterm infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recanalisation or persistence of reflux at 6 weeks · people requiring intervention for short saphenous vein varices
Endovenous laser ablation probably leads to lower recanalisation or persistence of reflux at 6 weeks compared with conventional surgery (moderate certainty).
1 finding from 1 review
Recurrence · people requiring intervention for short saphenous vein varices
1 finding from 1 review